New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential.
about
A practical guide to the therapy of narcolepsy and hypersomnia syndromesPotential adverse effects of amphetamine treatment on brain and behavior: a reviewNew and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children.Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.Abnormal behaviors and microstructural changes in white matter of juvenile mice repeatedly exposed to amphetamine.Psychopharmacology: concepts and opinions about the use of stimulant medications.ADHD: does parenting style matter?Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder.The effects of methylphenidate on cognitive control in active methamphetamine dependence using functional magnetic resonance imaging.Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?Management of attention-deficit hyperactivity disorder.Potential impact of ADHD with stimulant medication label on teacher expectations.Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities.Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis.Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder
P2860
Q24623713-1675093B-2CFF-47A6-AAF8-44B6C5533D74Q24657966-4A767D39-9CFC-462A-99C1-8142204E75EDQ33881547-DACD142A-9071-4DAF-9674-4B14E63D5BF8Q34032634-C7059FA1-A4A1-4BF5-8E89-950D1F2A69E9Q34434809-8A7D45E4-0689-4525-9D4E-E7F5D78BDD76Q36168824-60DC71BF-4C74-4C0F-8E1B-B6C4AC018A2BQ37189436-3155D5C7-8711-43FB-81FA-374C9D913483Q37193364-8AFFF0C2-B765-469F-A2DB-9B58F947907DQ37561623-CEB6C3B0-3A87-47E7-ABFE-EAB5741E5CD0Q37620947-30128234-D9ED-4FD9-83D0-1841B6FF7A88Q37803420-F36EFCD0-8FED-49FA-8CC1-FBF98875D917Q37982103-F09E19AB-FFEF-4F76-935A-88EB9AC83117Q38445841-685F5EED-E95F-4F19-87CC-31809DED2082Q39944895-5DB34D73-C7FD-43A3-9CAD-563844B62ABEQ40207289-B37AD370-D294-4CBF-9A6E-673B40753CF5Q50623240-7C23A360-621F-48A7-B9D5-E88443FAA60BQ51948539-C1D43889-AD7A-433F-BA38-A111171E04C5Q57400056-B7250765-9D19-41FE-BF32-7F7AD9437C4E
P2860
New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
New formulations of stimulants ...... sorder: therapeutic potential.
@ast
New formulations of stimulants ...... sorder: therapeutic potential.
@en
type
label
New formulations of stimulants ...... sorder: therapeutic potential.
@ast
New formulations of stimulants ...... sorder: therapeutic potential.
@en
prefLabel
New formulations of stimulants ...... sorder: therapeutic potential.
@ast
New formulations of stimulants ...... sorder: therapeutic potential.
@en
P1433
P1476
New formulations of stimulants ...... sorder: therapeutic potential.
@en
P2093
Daniel F Connor
Ronald J Steingard
P304
P356
10.2165/00023210-200418140-00005
P577
2004-01-01T00:00:00Z
P6179
1018809121